Nylim GBL Ety R&D LDR ETF-UiWRNDETF
13F holders, Q3 2025 (September 30)3holders
0new positions
0sold out
$36.03avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($6.8M), GTS Securities LLC ($668K) and UBS Group AG ($4K).
- Company
- Nylim GBL Ety R&D LDR ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q3 2025)
- CUSIP
- 45409B255
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 3,010 shares bought and 54 shares sold, net +2,956 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $6.8M |
| GTS Securities LLC | 0.03% | Add +19.4% | 18,538 | $668K |
| UBS Group AG | 0.00% | Reduce -33.8% | 106 | $4K |
"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.